Alimentiv is a specialized gastrointestinal clinical research organization (CRO) dedicated to transforming the lives of people living with GI diseases. The company delivers full-service clinical trials with deep expertise in gastroenterology, combining scientific leadership and operational excellence to ensure exceptional outcomes.
Alimentiv offers end-to-end solutions including clinical trial services, medical imaging, histopathology, biomarker analysis, and consulting. With a focus exclusively on GI research, it supports global trials through advanced modalities such as centralized endoscopy, AI-powered imaging, and precision medicine.
The company powers innovation in gastrointestinal science, supporting over 70% of IBD compounds in development and publishing over 200 peer-reviewed studies in the last five years. Alimentiv operates globally with access to more than 5,000 sites across 60+ countries.
